Elastase in diabetes study v1.0
Research type
Research Study
Full title
The measurement of faecal elastase to investigate exocrine pancreatic insufficiency in type 1 diabetic patients.
IRAS ID
197850
Contact name
Gemma Reidy
Contact email
Sponsor organisation
UHCW NHS Trust
Duration of Study in the UK
0 years, 3 months, 2 days
Research summary
Elastase is produced by the pancreas and is required for the digestion of fat in the gut. A lack of this enzyme results in malnutrition, fatty stools, gastrointestinal (GI) symptoms and wasting. As the enzyme passes through the intestines, it is not degraded so it can be measured in faeces. It has been reported that there may be an increased incidence of insufficiency in diabetic patients, leading to the problems mentioned previously as well as increased difficulty in maintaining their blood glucose levels. Therefore measurement of faecal elastase in these patients may be indicated.
This project will include a full method evaluation of a faecal elastase assay that can be performed at the UHCW laboratory. Through the diabetes clinics, type 1 insulin dependent diabetics will be recruited, and their faecal elastase measured. Project information will be posted prior to their usual appointment, and if they wish to participate they can consent during the appointment. A stool collection device and questionnaire will then be given out in the clinic, to be completed at home and returned by post to the laboratory. On arrival the stool samples will be stored at -20oC and analysed in batches. Results regarded as a low level of faecal elastase (<200ug/g) will be returned to the patient's diabetes consultant for follow up.The data collected from the elastase measurement and questionnaires will be collated and any statistical trends will be identified. This information will then be discussed with the diabetes teams to decide if routine faecal elastase testing of particular patients is warranted.
REC name
London - Stanmore Research Ethics Committee
REC reference
16/LO/0661
Date of REC Opinion
19 Apr 2016
REC opinion
Further Information Favourable Opinion